News

World Class Hospitals Join DNA Damage Response Consortium to Bring Forward New Treatments for Adults and Children with Brain Cancer Researchers from St. Jude Children’s Research Hospital, NYU, UCSF, and the University of Minnesota join National Brain Tumor Society and Yale-led Initiative   Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced new partners for its DNA Damage Response Consortium. Joining the initiative are world-class experts in adult and pediatric neuro-oncology […] March 28, 2023

NBTS Brain Tumor Clinical Trials Report: Q4 2021 It can be hard to keep track of new clinical trial opportunities opening across the United States, especially as we continue to navigate the public health crisis created by the coronavirus (COVID-19). There are many clinical trials actively enrolling patients, and this report provides a summary of the studies that have recently opened or started […] January 13, 2022

From the CEO’s Desk: Reflecting on 2018 Greetings and happy holidays to the brain tumor community, Before we turn over a new year, I wanted to take the opportunity to thank our amazing community of supporters, advocates, volunteers, and partners for making 2018 another year of great progress and momentum in the effort to conquer and cure brain tumors. Though we know […] December 27, 2018

SNO-Cap 2018: Recapping The Annual Meeting and Education Day of the Society for Neuro-Oncology The Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) continues to grow. Each of the last few years, SNO has reported new records for conference registration, attendees, and the number of presentations submitted for consideration. The 23rd annual SNO meeting in New Orleans, LA from Thursday, November 15 through Sunday, November 18 […] December 17, 2018

Passionate About Patients: Q&A With New NBTS Chief Scientific Officer, Kirk Tanner A couple of weeks ago, we introduced Kirk Tanner, PhD, as the National Brain Tumor Society’s new Chief Scientific Officer. The official announcement contained a good deal of biographical information regarding Kirk’s education, work history, and experience helping to develop new medicines as a senior director, staff scientist, and oncology research leader for a major […] November 30, 2018